Xtant Medical (US:XTNT)2025-03-06 21:10Financial Reporting - Xtant Medical Holdings, Inc. reported financial results for Q4 and the full year 2024 on March 6, 2025[5]. - The financial results announcement includes a press release detailing the fourth quarter and full year 2024 performance[19]. - The report does not provide specific numerical data regarding revenue or net income/loss for the reported periods[5]. - The report was signed by Scott Neils, Chief Financial Officer, indicating formal acknowledgment of the financial disclosures[22]. Non-GAAP Measures - The company utilizes non-GAAP adjusted EBITDA to provide insights into its core operational performance, excluding items like separation-related expenses and legal settlements[7][10]. - Non-GAAP adjusted EBITDA is defined as net income/loss from operations before depreciation, amortization, interest expense, and income tax provision, adjusted for specific non-recurring items[7]. - The company believes that non-GAAP measures facilitate internal comparisons to historical results and assist in budgeting and resource allocation decisions[8]. - The company emphasizes that non-GAAP financial measures should be evaluated alongside GAAP measures for a comprehensive understanding of financial results[17]. Company Information - The company is listed on NYSE American LLC under the trading symbol XTNT[3]. - The financial results are part of the company's ongoing strategy to enhance operational transparency and investor understanding[8].